Found: 30
Select item for more details and to access through your institution.
The effect of type 2 diabetes and diabetic peripheral neuropathy on predictive grip force control.
- Published in:
- Experimental Brain Research, 2023, v. 241, n. 11/12, p. 2605, doi. 10.1007/s00221-023-06705-7
- By:
- Publication type:
- Article
The impact of diabetic peripheral neuropathy on pinch proprioception.
- Published in:
- Experimental Brain Research, 2019, v. 237, n. 12, p. 3165, doi. 10.1007/s00221-019-05663-3
- By:
- Publication type:
- Article
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2023.1284444
- By:
- Publication type:
- Article
CIDP prognosis in patients with IVIG treatment‐related fluctuations.
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 1, p. 69, doi. 10.1002/mus.27746
- By:
- Publication type:
- Article
Phase II trial of methotrexate in myasthenia gravis.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1275, n. 1, p. 23, doi. 10.1111/j.1749-6632.2012.06804.x
- By:
- Publication type:
- Article
A secondary analysis of PAIN‐CONTRoLS: Pain's impact on sleep, fatigue, and activities of daily living.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 4, p. 404, doi. 10.1002/mus.27637
- By:
- Publication type:
- Article
Non‐dystrophic myotonia: 2‐year clinical and patient reported outcomes.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 2, p. 148, doi. 10.1002/mus.27649
- By:
- Publication type:
- Article
Open‐label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 1, p. 71, doi. 10.1002/mus.27560
- By:
- Publication type:
- Article
Rituximab in refractory chronic inflammatory demyelinating polyneuropathy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part II: New and novel agents.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part I: Traditional agents.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
When should you order genetic testing for patients with cryptogenic neuropathy? Let the data do the talking.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
An instrumented timed up and go in facioscapulohumeral muscular dystrophy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Creutzfeldt-Jakob disease presenting as bulbar palsy.
- Published in:
- Muscle & Nerve, 2010, v. 42, n. 5, p. 833, doi. 10.1002/mus.21849
- By:
- Publication type:
- Article
Clinical findings in MuSK-antibody positive myasthenia gravis: A U.S. experience.
- Published in:
- Muscle & Nerve, 2010, v. 41, n. 3, p. 370, doi. 10.1002/mus.21533
- By:
- Publication type:
- Article
MRI tissue characterization of experimental cerebral ischemia in rat.
- Published in:
- Journal of Magnetic Resonance Imaging, 2003, v. 17, n. 4, p. 398, doi. 10.1002/jmri.10256
- By:
- Publication type:
- Article
Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72355-6
- By:
- Publication type:
- Article
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 1, p. 68, doi. 10.1001/jamaneurol.2020.2590
- By:
- Publication type:
- Article
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 5, p. 582, doi. 10.1001/jamaneurol.2019.5125
- By:
- Publication type:
- Article
Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial.
- Published in:
- Physical Therapy, 2017, v. 97, n. 1, p. 20, doi. 10.2522/ptj.20160200
- By:
- Publication type:
- Article
Safety of Aerobic Exercise in People With Diabetic Peripheral Neuropathy: Single-Group Clinical Trial.
- Published in:
- Physical Therapy, 2015, v. 95, n. 2, p. 223, doi. 10.2522/ptj.20140108
- By:
- Publication type:
- Article
Targeting protein homeostasis in sporadic inclusion body myositis.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 331, p. 1, doi. 10.1126/scitranslmed.aad4583
- By:
- Publication type:
- Article
Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 5, p. 1417, doi. 10.1111/ene.15745
- By:
- Publication type:
- Article
Postprocedural neuropathy after atrial fibrillation ablation.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2013, v. 36, n. 3, p. 279, doi. 10.1007/s10840-012-9724-z
- By:
- Publication type:
- Article
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.
- Published in:
- Statistics in Medicine, 2015, v. 34, n. 7, p. 1134, doi. 10.1002/sim.6403
- By:
- Publication type:
- Article
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled trial.
- Published in:
- Journal of the Peripheral Nervous System, 2023, v. 28, n. 3, p. 436, doi. 10.1111/jns.12573
- By:
- Publication type:
- Article
2269-PUB: Early Attrition from a Randomized Lifestyle Modification Protocol.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2269-PUB
- By:
- Publication type:
- Article
2243-PUB: Impact of Sudomotor Impairment on Physical Fatigue after 16 Weeks of Aerobic Exercise.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2243-PUB
- By:
- Publication type:
- Article